Effect of Immunomodulatory Artificial Blood Exchange (IABX) on Guinea Pig-to-Rat Heart Xenografts

アクセス数 : 1449
ダウンロード数 : 106

今月のアクセス数 : 1
今月のダウンロード数 : 0
ファイル情報(添付)
HiroshimaJMedSci_43_153.pdf 1.51 MB 種類 : 全文
タイトル ( eng )
Effect of Immunomodulatory Artificial Blood Exchange (IABX) on Guinea Pig-to-Rat Heart Xenografts
作成者
Wada Seishi
Murakami Hironobu
Kajihara Hiroki
Matsuura Yuichiro
収録物名
Hiroshima Journal of Medical Sciences
43
4
開始ページ 153
終了ページ 161
収録物識別子
[PISSN] 0018-2052
[EISSN] 2433-7668
[NCID] AA00664312
抄録
The aim of this study was to assess the effectiveness of pregraft immunomodulatory artificial blood exchange (IABX) in a guinea pig-to-rat xeno discordant heart transplantation, using an artificial blood (FC43 emulsion: The Green Cross, Japan) in exchange for a large volume of whole blood to remove humoral immune factors en bloc from the recipient rat. In the rats treated with IABX, rhythmic beating of the grafted heart was maintained for 2 hr, whereas the untreated heart beat lasted for only 15.2 ± 5.2 min (n=6). In the graft hearts treated with IABX, no pathologic changes such as multiple coronary thromboses due to hyperacute rejection (HAR) were observed. Humoral immune factors (natural-IgM titer, ACH50 and CH50 complement activities, platelet count, prothrombin time (PT), activated partial thromboplastin time (APTT) and fibrinogen serum concentration), which are thought to contribute to HAR, decreased significantly following the IABX treatment.  

We conclude that IABX is an efficient method for prolonging the survival time of guinea pig heart xenografts by inhibiting thrombus formation in the xeno-graft heart. It was confirmed that IABX could remove recipient humoral immune factors en bloc.
著者キーワード
Xeno discordant transplantation
Hyperacute rejection
Artificial blood
Blood exchange
内容記述
This study was supported by The Green Cross Co.,Ltd.
NDC分類
医学 [ 490 ]
言語
英語
資源タイプ 紀要論文
出版者
Hiroshima University Medical Press
発行日 1994-12
出版タイプ Version of Record(出版社版。早期公開を含む)
アクセス権 オープンアクセス
収録物識別子
[ISSN] 0018-2052
[NCID] AA00664312